We assessed the influence of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following influenza vaccination in patients with rheumatoid arthritis (RA).
Publication
Annals of the rheumatic diseases, 2012, Vol 71, Issue 12, p2006